J&J’s Risperdal Gets “Approvable” Letter For Teen Schizophrenia, Bipolar Mania
Risperdal would compete with Lilly’s Zyprexa, which has also received an approvable letter from the agency, Lilly tells “The Pink Sheet” DAILY.
Risperdal would compete with Lilly’s Zyprexa, which has also received an approvable letter from the agency, Lilly tells “The Pink Sheet” DAILY.